Education
About Us
Working with TipRanks
Follow Us
Envista Holdings Corp (NVST)
NYSE:NVST
NVST Stock Chart & Stats
$29.44
-$0.72(-3.69%)
At close: 4:00 PM EST
$29.44
-$0.72(-3.69%)
Day’s Range― - ―
52-Week Range$14.22 - $30.42
Previous CloseN/A
Volume757.64K
Average Volume (3M)3.20M
Market Cap
$4.82B
Enterprise Value$5.34B
Total Cash (Recent Filing)$1.21B
Total Debt (Recent Filing)$1.71B
Price to Earnings (P/E)107.1
Beta0.93
Next Earnings
May 06, 2026EPS Estimate
0.31Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.38
Shares Outstanding163,875,400
10 Day Avg. Volume2,459,137
30 Day Avg. Volume3,201,902
Financial Highlights & Ratios
PEG Ratio-0.74
Price to Book (P/B)1.17
Price to Sales (P/S)1.34
P/FCF Ratio15.83
Enterprise Value/Market Cap1.11
Enterprise Value/Revenue1.96
Enterprise Value/Gross Profit3.57
Enterprise Value/Ebitda15.07
Forecast
1Y Price Target
$28.50Price Target Upside-3.19% Downside
Rating ConsensusModerate Buy
Number of Analyst Covering14
EPS Forecast (FY)1.41
Revenue Forecast (FY)$2.84B
Bulls Say, Bears Say
Bulls Say
Commercial Investments Driving Market ShareCommercial and research investments are supporting market share gains by strengthening product offerings and expanding sales efforts.
Pricing And Volume-driven Revenue MomentumPrice increases combined with volume improvements helped results beat consensus and supported guidance that implies continued revenue momentum.
Product Launches And InnovationNew product launches materially contributed to recent revenue, and a pipeline of additional launches is expected to sustain future growth.
Bears Say
Macroeconomic Pressure On Patient DemandBroader macroeconomic conditions and elevated interest rates are pressuring patient flow and willingness to spend, especially for higher-cost elective procedures, which could weigh on revenue.
One-time And Deferred Order EffectsReported results were supported by deferred partner orders and one-time compensation effects, creating risk that recent gains may not be sustainable.
Valuation Already Reflects ImprovementCurrent valuation appears to price in much of the company's improvement, prompting analysts to view upside as limited and maintain cautious ratings.
Envista Holdings News
NVST FAQ
What was Envista Holdings Corp’s price range in the past 12 months?
Envista Holdings Corp lowest stock price was $14.22 and its highest was $30.42 in the past 12 months.
What is Envista Holdings Corp’s market cap?
Envista Holdings Corp’s market cap is $4.82B.
When is Envista Holdings Corp’s upcoming earnings report date?
Envista Holdings Corp’s upcoming earnings report date is May 06, 2026 which is in 64 days.
How were Envista Holdings Corp’s earnings last quarter?
Envista Holdings Corp released its earnings results on Feb 05, 2026. The company reported $0.38 earnings per share for the quarter, beating the consensus estimate of $0.323 by $0.057.
Is Envista Holdings Corp overvalued?
According to Wall Street analysts Envista Holdings Corp’s price is currently Overvalued.
Does Envista Holdings Corp pay dividends?
Envista Holdings Corp does not currently pay dividends.
What is Envista Holdings Corp’s EPS estimate?
Envista Holdings Corp’s EPS estimate is 0.31.
How many shares outstanding does Envista Holdings Corp have?
Envista Holdings Corp has 163,875,400 shares outstanding.
What happened to Envista Holdings Corp’s price movement after its last earnings report?
Envista Holdings Corp reported an EPS of $0.38 in its last earnings report, beating expectations of $0.323. Following the earnings report the stock price went up 17.766%.
Which hedge fund is a major shareholder of Envista Holdings Corp?
Currently, no hedge funds are holding shares in NVST
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Envista Holdings Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$28.50 (-3.19% Downside)
$28.50 (-3.19% Downside)
Blogger Sentiment
Bullish
NVST Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 786.7K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▼ 1.0%
Last 30 Days ▲ 22.9%
Last 30 Days ▲ 22.9%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
47.34%
12-Months-Change
Fundamentals
Return on Equity
1.56%
Trailing 12-Months
Asset Growth
5.83%
Trailing 12-Months
Company Description
Envista Holdings Corp
Envista Holdings Corp. manufactures and markets dental products for diagnosing, treating and preventing dental conditions. The company is headquartered in Brea, California and currently employs 12,800 full-time employees. The firm provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone. The firm operates through two segments: Specialty Products & Technologies, and Equipment & Consumables. Its Specialty Products & Technologies segment develops, manufactures and markets dental implant systems, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. Its Equipment & Consumables segment develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems; treatment units and other dental practice equipment; endodontic systems and related consumables; restorative materials and instruments, rotary burs, impression materials, bonding agents and cements and infection prevention products.
NVST Company Deck
NVST Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call emphasized strong operational and financial progress: broad-based revenue growth, notable margin and EPS expansion, high free cash flow conversion, product innovation momentum, cost reduction in G&A, and a return to shareholder-friendly actions (repurchases). Notable risks include FX comparability effects, tariff headwinds (~$30M in 2025; ~$40M annualized in 2026), China VBP timing uncertainty, some segment margin pressure (Diagnostics/Equipment) and the fact that portions of Q4 growth were aided by non-recurring items. On balance, the company presented measurable, repeatable improvements and conservative guidance that account for known risks while projecting continued progress in 2026.View all NVST earnings summariesNVST Revenue Breakdown
63.99% Specialty Products & Technologies
36.01% Equipment & Consumables
NVST Stock 12 Month Forecast
Average Price Target
$28.50
▼(-3.19% Downside)
Technical Analysis
DENTSPLY SIRONA
―
Disc Medicine
―
Clover Health Investments
―
AbCellera Biologics
―
Bausch + Lomb Corporation
―
Ownership Overview
Currently, No data available
---